Diabetes
Feature
Dulaglutide meets primary endpoint in REWIND
.
Conference Coverage
Sleep: The new frontier in cardiovascular prevention
MUNICH - Sleep that’s too little, too much, or too disrupted boosts cardiovascular risk.
News
Canagliflozin approved for cardiovascular event risk reduction
.
Conference Coverage
Smart insoles reduce ‘high-risk’ diabetic foot ulcer recurrence
BERLIN – Novel plantar pressure–sensing insoles reduced the recurrence of diabetic foot ulcers by 71% in a randomized, single-blind controlled...
Conference Coverage
Platelet-rich patch helps heal difficult diabetic foot ulcers
BERLIN – LeucoPatch, which contains patients’ own platelets, fibrin, and leukocytes, enabled more diabetic ulcers to heal versus standard care.
From the Journals
Six PAD diagnostic tests vary widely in patients with diabetes
From the Journals
Obesity tied to improved inpatient survival of patients with PAD
Conference Coverage
Weight-loss drug lorcaserin’s glycemic effects revealed
The appetite-suppressant drug lorcaserin has benefits ranging from lower rates of incident type 2 diabetes mellitus and improved glycemic control...
Conference Coverage
Guidelines outline patient-centered approach to type 2 diabetes
BERLIN – The ADA and EASD have issued their 2018 Consensus Report on the management of hyperglycemia in type 2 diabetes.
Conference Coverage
‘Twincreatin’ produces ‘impressive’ HbA1c, weight control in T2DM
BERLIN – HbA1c and body weight were significantly lowered, compared with placebo and dulaglutide, by the dual GIP/GLP-1 receptor agonist LY3298176...
Conference Coverage
Gastric banding, metformin “equal” for slowing early T2DM progression
BERLIN – Gastric banding surgery and metformin improved insulin sensitivity, suggestive of preserved beta-cell function.